✦ LIBER ✦

Phase II study of S-1 and irinotecan combination chemotherapy as a first-line therapy for patients with advanced gastric cancer. Korean Cancer Study Group Protocol ST05-02

✍ Scribed by Hye J KANG; Sang H CHO; Suk J OH; Sung H YANG; Moon H LEE; Eun-Kee SONG; Hyun C CHUNG; Im I NA; Baek-Yeol RYOO

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel and capec

✍ Kang, H J; Chang, H M; Kim, T W; Ryu, M-H; Sohn, H-J; Yook, J H; Oh, S T; Kim, B 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Phase II study of biweekly docetaxel and

✍ Chikara Kunisaki; Masazumi Takahashi; Hirochika Makino; Takashi Oshima; Shoichi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 272 KB

A phase II study of combination therapy

✍ Manabu Shiozawa; Makoto Akaike; Nobuhiro Sugano; Kazuhito Tsuchida; Naoto Yamamo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 347 KB

A phase II study of capecitabine and doc

✍ Park, Y H; Ryoo, B-Y; Choi, S-J; Kim, H-T 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

A phase II study of capecitabine plus 3-

✍ Park, Y H; Kim, B-S; Ryoo, B-Y; Yang, S H 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

A phase II study of weekly irinotecan as

✍ Hideki Ueno; Takuji Okusaka; Akihiro Funakoshi; Hiroshi Ishii; Kenji Yamao; Osam 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB